Andros Pharmaceuticals Co., Ltd.

Andros Pharmaceuticals Co., Ltd.

TTPEX:6917
32.00
TWD
-0.45
(-1.39%)
1.70BMarket Cap

Latest Stock Split

Sep 25, 2025

931:901

For every 901 shares held, investors received 931. The price per share adjusted from $21.10 to $20.42.

The split itself did not change the total investment value.

Use this split data in your app

Build with our data

Stock Split History

  1. Sep 25, 2025
    Before$21.10
    Split ratio931:901
    After$20.42
    Forward
  2. Jul 18, 2023
    Before$35.90
    Split ratio194:183
    After$33.86
    Forward

About Andros Pharmaceuticals Co., Ltd. stock splits

Andros Pharmaceuticals Co., Ltd. (TPEX:6917) operates in the Pharmaceuticals: major industry.

Andros Pharmaceuticals Co., Ltd. company overview

When did Andros Pharmaceuticals Co., Ltd. stock split?

Andros Pharmaceuticals Co., Ltd.'s most recent stock split was on September 25, 2025. It was a 931-for-901 forward split, so shareholders received 931 shares for every 901 they held.

What is Andros Pharmaceuticals Co., Ltd.'s stock split history?

Andros Pharmaceuticals Co., Ltd. (TPEX:6917) has split its stock 2 times: a 194-for-183 split on July 18, 2023 and a 931-for-901 split on September 25, 2025.

How many times has Andros Pharmaceuticals Co., Ltd. stock split?

Andros Pharmaceuticals Co., Ltd. has split its stock 2 times. This history records 2 forward splits between July 18, 2023 and September 25, 2025.

What is a stock split?

A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In Andros Pharmaceuticals Co., Ltd.'s 931-for-901 split on September 25, 2025, every 901 shares became 931 shares.

Will Andros Pharmaceuticals Co., Ltd. split its stock again?

Andros Pharmaceuticals Co., Ltd. has not announced a new split in our records. Its most recent split was on September 25, 2025, 1 year ago. Companies announce splits in advance, and any new TPEX:6917 split will appear on this page.